Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents.

Allergy and asthma proceedings : the official journal of regional and state allergy societies

Volumn 30, Issue 4, 2009, Pages 406-412

  Anolik, Robert ^a   Pearlman, David ^a   Teper, Ariel ^a   Gates, Davis ^a  

^a Allergy and Asthma Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; MOMETASONE FUROATE; PREGNANE DERIVATIVE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HAY FEVER; HUMAN; LACRIMAL FLUID; MALE; MULTICENTER STUDY; NOSE OBSTRUCTION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SECRETION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NASAL OBSTRUCTION; PREGNADIENEDIOLS; RHINITIS, ALLERGIC, SEASONAL; TEARS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77952242221     PISSN: None     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3238     Document Type: Article

References (0)